Next Article in Journal
Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?
Previous Article in Journal
Controlled Release of Doxorubicin from the Drug Delivery Formulation Composed of Single-Walled Carbon Nanotubes and Congo Red: A Molecular Dynamics Study and Dynamic Light Scattering Analysis
Previous Article in Special Issue
Crystallisation Behaviour of Pharmaceutical Compounds Confined within Mesoporous Silicon
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Erratum: Sun, X.; et al. Folic Acid and PEI Modified Mesoporous Silica for Targeted Delivery of Curcumin. Pharmaceutics, 2019, 11, 430

School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China
*
Author to whom correspondence should be addressed.
Pharmaceutics 2020, 12(7), 623; https://doi.org/10.3390/pharmaceutics12070623
Submission received: 9 June 2020 / Accepted: 11 June 2020 / Published: 3 July 2020
(This article belongs to the Special Issue Porous Silicon for Drug Delivery)
The authors wish to make the following corrections to this paper [1]:
  • In Figure 2d–f, the TEM images of (d) MSN, (e) MSN-PEI, and (f) MSN-PEI-FA ruler had an error in the unit when enlarging the annotation;
  • In Figure 6a, there is something wrong with the mark of concentration unit of Cur;
  • The dose of Cur in the experiment was from 10 to 200 µg/mL, but it was mistakenly written as 10–20 µg/mL in the manuscript.
After the publication of this work, we noted the mistake and issued an erratum for correction. The corresponding sentence, Figures 2 and 6a have now been corrected in this erratum.
“The MTT method was used to evaluate the cytotoxicity of MSN-PEI-FA/Cur on colon cancer cells. MSN-PEI-FA/Cur solution of concentrations of 10–200 µg/mL was prepared in PBS”.
The authors would like to apologize for any inconvenience caused to the readers by these changes.

References

  1. Sun, X.; Wang, N.; Yang, L.-Y.; Ouyang, X.-K.; Huang, F. Folic Acid and PEI Modified Mesoporous Silica for Targeted Delivery of Curcumin. Pharmaceutics 2019, 11, 430. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 2. SEM images of (a) MSN, (b) MSN-PEI, and (c) MSN-PEI-FA; the TEM images of (d) MSN, (e) MSN-PEI, and (f) MSN-PEI-FA.
Figure 2. SEM images of (a) MSN, (b) MSN-PEI, and (c) MSN-PEI-FA; the TEM images of (d) MSN, (e) MSN-PEI, and (f) MSN-PEI-FA.
Pharmaceutics 12 00623 g001
Figure 6. (a) Inhibition rate of Cur and MSN-PEI-FA/Cur; fluorescence microscopic images of LS174T for coumarin-loaded MSN (b), MSN–PEI (c), and MSN–PEI-FA (d) intake experiments.
Figure 6. (a) Inhibition rate of Cur and MSN-PEI-FA/Cur; fluorescence microscopic images of LS174T for coumarin-loaded MSN (b), MSN–PEI (c), and MSN–PEI-FA (d) intake experiments.
Pharmaceutics 12 00623 g002

Share and Cite

MDPI and ACS Style

Sun, X.; Wang, N.; Yang, L.-Y.; Ouyang, X.-K.; Huang, F. Erratum: Sun, X.; et al. Folic Acid and PEI Modified Mesoporous Silica for Targeted Delivery of Curcumin. Pharmaceutics, 2019, 11, 430. Pharmaceutics 2020, 12, 623. https://doi.org/10.3390/pharmaceutics12070623

AMA Style

Sun X, Wang N, Yang L-Y, Ouyang X-K, Huang F. Erratum: Sun, X.; et al. Folic Acid and PEI Modified Mesoporous Silica for Targeted Delivery of Curcumin. Pharmaceutics, 2019, 11, 430. Pharmaceutics. 2020; 12(7):623. https://doi.org/10.3390/pharmaceutics12070623

Chicago/Turabian Style

Sun, Xiaoxiao, Nan Wang, Li-Ye Yang, Xiao-Kun Ouyang, and Fangfang Huang. 2020. "Erratum: Sun, X.; et al. Folic Acid and PEI Modified Mesoporous Silica for Targeted Delivery of Curcumin. Pharmaceutics, 2019, 11, 430" Pharmaceutics 12, no. 7: 623. https://doi.org/10.3390/pharmaceutics12070623

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop